Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study of RMC-6291 with ivonescimab drug combination in patients with advanced RAS‑mutated solid tumors
Not yet recruiting
Investigated Diseases:Investigated Drugs:- (2S)-2-CYCLOPENTYL-2-[(5S)-2-[(2R,3R)-3-CYCLOPROPYL-1-METHYLAZIRIDINE-2-CARBONYL]-2,7-DIAZASPIRO[4.4]NONAN-7-YL]-N-[(6S,8S,14S)-21-[5-(4-CYCLOPROPYLPIPERAZIN-1-YL)-2-[(1S)-1-METHOXYETHYL]PYRIDIN-3-YL]-18,18-DIMETHYL-9,15-DIOXO-22-(2,2,2-TRIFLUOROETHYL)-5,16-DIOXA-2,10,22,28-TETRAZAPENTACYCLO[18.5.2.12,6.110,14.023,27]NONACOSA-1(26),20,23(27),24-TETRAEN-8-YL]ACETAMIDE
- Cetuximab
- Ivonescimab
+3
Phase I/II study of DJI136 with drug combination in adult patients with extensive-stage small cell lung cancer
Not yet recruiting
Investigated Diseases:Investigated Drugs:
Anti‑PD1 Therapy with pembrolizumab and cemiplimab in first‑line advanced non‑small cell lung cancer patients with high PD‑L1 expression
Not yet recruiting
Investigated Diseases:Investigated Drugs:
Study on Colchicine and Tiemonium Methylsulphate for Reducing Atherosclerosis in Cancer Patients Undergoing Immune Therapy
Not yet recruiting
Investigated Diseases:Investigated Drugs:
Study of Brentuximab Vedotin with Drug Combination for Untreated CD30-expressing Peripheral T-cell Lymphoma Patients
Not yet recruiting
Investigated Diseases:Investigated Drugs:
Study of Propranolol and Vinorelbine for Children and Teenagers with Refractory or Relapsing Solid Tumors
Not yet recruiting
Investigated Diseases:Investigated Drugs: